{"id":"W2970927649","doi":"10.1016/j.cmet.2019.08.015","title":"SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus","year":2019,"lang":"en","type":"letter","venue":"Cell Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Robarts Clinical Trials; Western University; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; Canadian Institutes of Health Research; St. Jude Medical; Schulich School of Medicine and Dentistry, Western University; Servier; Ontario Ministry of Research, Innovation and Science; Ontario Ministry of Research and Innovation; Bayer Fund; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Mayo Clinic; Merck; GlaxoSmithKline; Abbott Laboratories; CSL Behring; Chiesi Farmaceutici; Icahn School of Medicine at Mount Sinai; Cleveland Clinic; Bristol-Myers Squibb; Boehringer Ingelheim España; Eli Lilly and Company; AstraZeneca; University of Toronto; American College of Cardiology Foundation; Boehringer Ingelheim; Amgen; Sanofi","keywords":"Empagliflozin; Mace; Medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Internal medicine; EMPA; Myocardial infarction; Endocrinology; Conventional PCI","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002510239,0.0007504969,0.001379861,0.0005283839,0.00006449161,0.0001054372,0.0001513712,0.0004475435,0.0001313925],"category_scores_gemma":[0.00002170915,0.0005326608,0.0002054566,0.0007028088,0.0000808419,0.0001926105,0.00009094177,0.000915937,0.0002411744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001592695,"about_ca_system_score_gemma":0.0002613374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001910253,"about_ca_topic_score_gemma":0.00003218862,"domain_scores_codex":[0.9967323,0.0001641151,0.0004644971,0.000938733,0.0008365994,0.0008637791],"domain_scores_gemma":[0.998362,0.0000984993,0.0003317746,0.0008814838,0.000211373,0.0001148905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001193345,0.005814269,0.1837221,0.03309191,0.01084417,0.008580009,0.00275646,0.0004263685,0.03244538,0.00006417401,0.7066714,0.01439041],"study_design_scores_gemma":[0.01282964,0.001502049,0.01728993,0.002922107,0.009707206,0.00002649457,0.0002144407,0.0001539021,0.06810164,0.00003640667,0.8851834,0.00203277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767362,0.009242629,0.00001029117,0.00615694,0.0004632749,0.00456524,0.00003155525,0.0001778443,0.002615976],"genre_scores_gemma":[0.7622519,0.001608188,0.008107672,0.1867392,0.009541065,0.00238807,0.008212698,0.001200225,0.01995104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2144844,"threshold_uncertainty_score":0.9997125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006811304763485843,"score_gpt":0.1942229339252058,"score_spread":0.18741162916172,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}